Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
KEY PRODUCTS
KEY EXCIPIENTS
Reset all filters
01 1Pfanstiehl
Reset all filters
01 1MALTOSE MONOHYDRATE, HIGH PURITY, LOW ENDOTOXIN, LOW METALS, NF, JP, CHP
Reset all filters
01 1U.S.A
Reset all filters
01 1Active
Reset all filters
01 1Blank
Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38161
Submission : 2023-03-10
Status : Active
Type : IV
20
Pfanstiehl Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
One of their notable products is MALTOSE MONOHYDRATE, HIGH PURITY, LOW ENDOTOXIN, LOW METALS, NF, JP, CHP, with a corresponding US DMF Number 38161.
Remarkably, this DMF maintains an Active status since its submission on March 10, 2023, highlighting commitment to regulatory compliance.